Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE.

Published on Sep 30, 2008in Journal of Biochemistry and Molecular Biology
· DOI :10.5483/BMBRep.2008.41.9.626
Tadashi Kondo1
Estimated H-index: 1
Novel cancer biomarkers are required to achieve early diagnosis and optimized therapy for individual patients. Cancer is a disease of the genome, and tumor tissues are a rich source of cancer biomarkers as they contain the functional translation of the genome, namely the proteome. Investigation of the tumor tissue proteome allows the identification of proteomic signatures corresponding to clinico-pathological parameters, and individual proteins in such signatures will be good biomarker candidates. Tumor tissues are also a rich source for plasma biomarkers, because proteins released from tumor tissues may be more cancer specific than those from non-tumor cells. Two-dimensional difference gel electrophoresis (2D-DIGE) with novel ultra high sensitive fluorescent dyes (CyDye DIGE Fluor satulation dye) enables the efficient protein expression profiling of laser-microdissected tissue samples. The combined use of laser microdissection allows accurate proteomic profiling of specific cells in tumor tissues. To develop clinical applications using the identified biomarkers, collaboration between research scientists, clinicians and diagnostic companies is essential, particularly in the early phases of the biomarker development projects. The proteomics modalities currently available have the potential to lead to the development of clinical applications, and channeling the wealth of produced information towards concrete and specific clinical purposes is urgent. [BMB reports 2008; 41(9): 626-634] Biomarkers for better clinical outcome of cancer patients
  • References (56)
  • Citations (34)
#1Sophia Hober (KTH: Royal Institute of Technology)H-Index: 34
#2Mathias Uhlén (KTH: Royal Institute of Technology)H-Index: 90
Cited By34
#1Olga M. Ivanova (RAS: Russian Academy of Sciences)H-Index: 3
#2Rustam H. Ziganshin (RAS: Russian Academy of Sciences)H-Index: 14
Last.V. T. Ivanov (RAS: Russian Academy of Sciences)H-Index: 32
view all 9 authors...
#1Qihui Wang (Sichuan University)H-Index: 4
#2Qiaoling Yu (Sichuan University)H-Index: 3
Last.Yixiang Duan (Sichuan University)H-Index: 22
view all 4 authors...
#1Hadi MohammadiH-Index: 10
Last.Guy FradetH-Index: 25
view all 3 authors...
#1Pavel Gromov (The Breast Cancer Research Foundation)H-Index: 32
#2José Ma Moreira (UCPH: University of Copenhagen)H-Index: 2
Last.Irina Gromova (The Breast Cancer Research Foundation)H-Index: 33
view all 3 authors...
#1Andrei P. Drabovich (MSH: Mount Sinai Hospital, Toronto)H-Index: 21
#2Maria P. Pavlou (U of T: University of Toronto)H-Index: 5
Last.Eleftherios P. DiamandisH-Index: 97
view all 4 authors...
View next paperMultiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents